Logo image of NLS

NAUTILUS INC (NLS) Stock Fundamental Analysis

NYSE:NLS - New York Stock Exchange, Inc. - US63910B1026 - Common Stock - Currency: USD

0.8204  +0.08 (+11.2%)

After market: 0.85 +0.03 (+3.61%)

Fundamental Rating

2

Overall NLS gets a fundamental rating of 2 out of 10. We evaluated NLS against 31 industry peers in the Leisure Products industry. The financial health of NLS is average, but there are quite some concerns on its profitability. NLS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NLS has reported negative net income.
NLS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NLS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: NLS reported negative operating cash flow in multiple years.
NLS Yearly Net Income VS EBIT VS OCF VS FCFNLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

NLS's Return On Assets of -35.77% is on the low side compared to the rest of the industry. NLS is outperformed by 79.41% of its industry peers.
The Return On Equity of NLS (-84.89%) is worse than 76.47% of its industry peers.
Industry RankSector Rank
ROA -35.77%
ROE -84.89%
ROIC N/A
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
NLS Yearly ROA, ROE, ROICNLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

NLS's Gross Margin of 19.60% is on the low side compared to the rest of the industry. NLS is outperformed by 88.24% of its industry peers.
In the last couple of years the Gross Margin of NLS has declined.
The Profit Margin and Operating Margin are not available for NLS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.28%
GM growth 5Y-18.44%
NLS Yearly Profit, Operating, Gross MarginsNLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

NLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NLS has more shares outstanding
The number of shares outstanding for NLS has been increased compared to 5 years ago.
Compared to 1 year ago, NLS has a worse debt to assets ratio.
NLS Yearly Shares OutstandingNLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
NLS Yearly Total Debt VS Total AssetsNLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

NLS has an Altman-Z score of 1.84. This is not the best score and indicates that NLS is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.84, NLS is doing worse than 61.76% of the companies in the same industry.
The Debt to FCF ratio of NLS is 1.35, which is an excellent value as it means it would take NLS, only 1.35 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.35, NLS is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
NLS has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.24, NLS is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.35
Altman-Z 1.84
ROIC/WACCN/A
WACC11.43%
NLS Yearly LT Debt VS Equity VS FCFNLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

NLS has a Current Ratio of 1.99. This is a normal value and indicates that NLS is financially healthy and should not expect problems in meeting its short term obligations.
NLS has a Current ratio (1.99) which is comparable to the rest of the industry.
NLS has a Quick Ratio of 1.08. This is a normal value and indicates that NLS is financially healthy and should not expect problems in meeting its short term obligations.
NLS has a Quick ratio (1.08) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.08
NLS Yearly Current Assets VS Current LiabilitesNLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.92% over the past year.
Looking at the last year, NLS shows a very negative growth in Revenue. The Revenue has decreased by -40.47% in the last year.
The Revenue has been decreasing by -6.73% on average over the past years.
EPS 1Y (TTM)47.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.19%
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.73%
Sales Q2Q%-23.84%

3.2 Future

NLS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.62% yearly.
The Revenue is expected to grow by 5.08% on average over the next years.
EPS Next Y80.64%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.27%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NLS Yearly Revenue VS EstimatesNLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NLS Yearly EPS VS EstimatesNLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

NLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NLS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NLS Price Earnings VS Forward Price EarningsNLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, NLS is valued cheaply inside the industry as 97.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.42
EV/EBITDA N/A
NLS Per share dataNLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as NLS's earnings are expected to grow with 35.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.62%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NLS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NAUTILUS INC

NYSE:NLS (10/31/2023, 8:26:50 PM)

After market: 0.85 +0.03 (+3.61%)

0.8204

+0.08 (+11.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)08-09 2023-08-09/amc
Earnings (Next)11-08 2023-11-08/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners3.88%
Ins Owner Change0%
Market Cap29.14M
Analysts74.29
Price Target2.04 (148.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)31.45%
Min EPS beat(2)-3.09%
Max EPS beat(2)65.99%
EPS beat(4)2
Avg EPS beat(4)13.84%
Min EPS beat(4)-26.01%
Max EPS beat(4)65.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.4%
Min Revenue beat(2)-7.9%
Max Revenue beat(2)18.71%
Revenue beat(4)1
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-7.9%
Max Revenue beat(4)18.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.19%
EPS NY rev (1m)0%
EPS NY rev (3m)29.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF 2.42
P/OCF 1.3
P/B 0.49
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-1.5
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)0.34
FCFY41.34%
OCF(TTM)0.63
OCFY77.09%
SpS7.71
BVpS1.66
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.77%
ROE -84.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.6%
FCFM 4.4%
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.28%
GM growth 5Y-18.44%
F-Score4
Asset Turnover1.95
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.35
Debt/EBITDA N/A
Cap/Depr 87.18%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.08
Altman-Z 1.84
F-Score4
WACC11.43%
ROIC/WACCN/A
Cap/Depr(3y)122.77%
Cap/Depr(5y)113.7%
Cap/Sales(3y)2.79%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.19%
EPS Next Y80.64%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.73%
Sales Q2Q%-23.84%
Revenue Next Year1.27%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year92.9%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y126.3%
FCF growth 3YN/A
FCF growth 5Y-27.55%
OCF growth 1Y148.88%
OCF growth 3YN/A
OCF growth 5Y-11.65%